Dodge & Cox Biomarin Pharmaceutical Inc Transaction History
Dodge & Cox
- $166 Billion
- Q2 2025
A detailed history of Dodge & Cox transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Dodge & Cox holds 15,108,310 shares of BMRN stock, worth $859 Million. This represents 0.5% of its overall portfolio holdings.
Number of Shares
15,108,310
Previous 14,955,240
1.02%
Holding current value
$859 Million
Previous $1.06 Billion
21.44%
% of portfolio
0.5%
Previous 0.65%
Shares
23 transactions
Others Institutions Holding BMRN
# of Institutions
672Shares Held
185MCall Options Held
1.28MPut Options Held
1.1M-
Black Rock Inc. New York, NY22.7MShares$1.29 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.08 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$897 Million0.71% of portfolio
-
Viking Global Investors LP12.3MShares$699 Million2.14% of portfolio
-
State Street Corp Boston, MA8.85MShares$503 Million0.02% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.6B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...